ANAPTYSBIO, INC — Investor Relations & Filings
Filings indexed
636
across all filing types
Latest filing
2026-05-29
Regulatory Filings
Country
US
United States of America
Listing
US
ANAB
AnaptysBio, Inc. is a clinical-stage biotechnology company that focuses on the discovery and development of innovative immunology therapeutics. The company specializes in advancing immune cell-modulating antibodies designed to treat autoimmune and inflammatory diseases. Its therapeutic candidates target key pathways in the immune system to address significant unmet medical needs for various patient populations.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-29 | English | |
| 8-K | 2026-05-21 | English | |
| 8-K - ANAPTYSBIO, INC (0001370053) (Filer) | 2026-04-20 | English | |
| 4 - ANAPTYSBIO, INC (0001370053) (Issuer) | 2026-03-28 | English | |
| 8-K - ANAPTYSBIO, INC (0001370053) (Filer) | 2026-03-27 | English | |
| SCHEDULE 13G/A - ANAPTYSBIO, INC (0001370053) (Subject) | 2026-03-26 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47894171 | 8-K | 2026-05-29 | English | ||
| 46753425 | 8-K | 2026-05-21 | English | ||
| 34694408 | 8-K - ANAPTYSBIO, INC (0001370053) (Filer) | 2026-04-20 | English | ||
| 33067330 | 4 - ANAPTYSBIO, INC (0001370053) (Issuer) | 2026-03-28 | English | ||
| 33060272 | 8-K - ANAPTYSBIO, INC (0001370053) (Filer) | 2026-03-27 | English | ||
| 33051859 | SCHEDULE 13G/A - ANAPTYSBIO, INC (0001370053) (Subject) | 2026-03-26 | English | ||
| 32890702 | 10-K - ANAPTYSBIO, INC (0001370053) (Filer) | 2026-03-03 | English | ||
| 32890701 | 8-K - ANAPTYSBIO, INC (0001370053) (Filer) | 2026-03-03 | English | ||
| 29143910 | 4 Filing | 2026-02-13 | English | ||
| 29143925 | SCHEDULE 13G/A Filing | 2026-01-16 | English | ||
| 29143905 | 4 Filing | 2026-01-16 | English | ||
| 29143938 | 8-K Filing | 2026-01-09 | English | ||
| 29143920 | 4 Filing | 2026-01-09 | English | ||
| 29143912 | 4 Filing | 2026-01-09 | English | ||
| 29143909 | 4 Filing | 2026-01-09 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cabaletta Bio, Inc.
Develops engineered T cell therapies for B cell-mediated au…
|
CABA | US | Professional, scientific and te… |
|
Caliway
Develops small-molecule therapeutics for medical aesthetics…
|
6919 | TW | Professional, scientific and te… |
|
CALIX LIMITED
Develops industrial carbon capture and sustainable mineral …
|
CXL | AU | Professional, scientific and te… |
|
CAMBIUM BIO LIMITED
Clinical-stage developer of cellular therapies for ophthalm…
|
CMB | AU | Professional, scientific and te… |
|
CAMBRIDGE COGNITION HOLDINGS PLC
Develops digital solutions and a platform for CNS clinical …
|
COG | GB | Professional, scientific and te… |
|
CanBas Co.,Ltd.
A clinical-stage biopharmaceutical company developing novel…
|
4575 | JP | Professional, scientific and te… |
|
Captor Therapeutics S.A.
Develops Targeted Protein Degradation therapies for cancer …
|
CTX | PL | Professional, scientific and te… |
|
Cardiff Oncology, Inc.
A clinical-stage biotech developing cancer therapies that i…
|
CRDF | US | Professional, scientific and te… |
|
Cardio Diagnostics Holdings, Inc.
Develops AI-powered epigenetic and genetic tests for early …
|
CDIO | US | Professional, scientific and te… |
|
Cardiol Therapeutics Inc.
Clinical-stage company developing anti-inflammatory therapi…
|
CRDL | CA | Professional, scientific and te… |
ANAPTYSBIO, INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32596/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32596 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32596 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32596 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32596}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ANAPTYSBIO, INC (id: 32596)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.